A new study from TauRx reports success in reversing symptoms of Parkinson’s disease in mouse models treated with LTMX.
Browsing: Movement disorders
Russell Kern reports on the 6-month update on the first-in-human clinical study of neural stem cells in patients with Parkinson’s disease.
This review article from Journal of Comparative Effectiveness Research explores the use of tetrabenazine and valbenazine in treating tardive dyskinesia (TD), a movement disorder often induced by antipsychotic drugs.
Lauren Pulling sat down with Nicole Swann at Neuroscience 2017 to hear more about her work on a novel implantable device capable of delivering adaptive DBS.
Research presented today at SfN’s annual meeting has detailed advances in brain stimulation technologies revealing safer, more targeted means of studying brain function and treating neurological disorders.
Whilst at SfN’s Neuroscience 2017, Lauren Pulling sat down with Doris Doudet to hear more about her recent research, which has demonstrated elevated inflammation in the gut of a Parkinson’s disease rat model.
Researchers have demonstrated significant reductions in levels of fatigue for multiple sclerosis patients in a randomized trial assessing transcranial direct current stimulation.
Difficulty in turning in bed is rated as the most troublesome night-time symptom among Parkinson’s patients – this study aims to develop a practival objective method for home assessment of a patient’s ability to turn in bed.
Study suggests coffee not as much of a perk as previously thought for Parkinson’s symptoms.